Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
D
383930
vs
K
KOSPI 200
Over the past 12 months, DT&CRO Co Ltd has underperformed KOSPI 200, delivering a return of -14% compared to KOSPI 200's +85% growth.
Stocks Performance
383930 vs KOSPI 200
Performance Gap
383930 vs KOSPI 200
Performance By Year
383930 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
DT&CRO Co Ltd
Glance View
DT&CRO Co Ltd is a contract research organization that helps drug makers run clinical trials and handle the paperwork needed to bring new medicines to market. It plans and manages study sites, collects and checks trial data, and supports regulatory submissions so pharmaceutical and biotech clients can move a drug candidate through development more efficiently. Its customers are mainly drug companies and biotech firms that do not want to build a large in-house clinical development team. DT&CRO makes money by charging fees for specific trial services, project management, and related research support work. In practice, it acts as an outside partner that connects sponsors, hospitals, investigators, and regulators during the drug development process. What makes this business different is that it sits in the middle of a highly regulated process where experience, documentation, and local trial execution matter a lot. Instead of selling a physical product, DT&CRO sells specialized know-how and labor that help clients reduce trial complexity and keep studies moving within the rules.